This inventor holds 1 USPTO granted patent. Top assignee: Dana-Farber-Cancer Institute Inc.. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018
Title: Mark Theilmann: Innovator in Nucleic Acid Amplification
Introduction
Mark Theilmann is a notable inventor based in Summerland, California. He has made significant contributions to the field of molecular biology, particularly in the area of nucleic acid amplification. His innovative work has implications for various applications, including DNA nanostructure synthesis.
Latest Patents
Mark Theilmann holds a patent for "Selective nucleic acid amplification from nucleic acid pools." This patent provides methods for selectively amplifying in parallel tens of thousands of high-quality oligonucleotides without common sequences. The resultant oligonucleotides can be utilized for a variety of purposes and applications.
Career Highlights
Mark is associated with the Dana-Farber Cancer Institute Inc., where he continues to advance research in his field. His work is characterized by a commitment to improving methodologies in nucleic acid research.
Collaborations
Some of his notable coworkers include William M. Shih and Thorsten Lars Schmidt. Their collaborative efforts contribute to the innovative research environment at the Dana-Farber Cancer Institute.
Conclusion
Mark Theilmann's contributions to nucleic acid amplification represent a significant advancement in molecular biology. His innovative patent and ongoing work continue to influence the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile